To donate by check, phone, or other method, see our More Ways to Give page.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation on Wednesday. (Image: Social Security Works)
The U.S. Senate on Wednesday, with the help of crucial votes by Democrats, confirmed former Eli Lilly executive Alex Azar to become the nation's top healthcare administrator, provoking ire among progressives and healthcare advocates.
\u201cShame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry: https://t.co/b4Gqxvwedv\u201d— Social Security Works (@Social Security Works) 1516826042
Notable on the rollcall list, and the source of ire among critics, was the fact that six Democratic Senators--Doug Jones of Alabama, Tom Carper of Delaware, Chris Coons of Delaware,Joe Donnelly of Indiana, Heidi Heitkamp of North Dakota, and Joe Manchin of West Virginia --joined with Republicans and voted in favor. With the addition of Sen. Angus King, the Indepedent from Maine who caucuses with the Democrats, that gave Azar the needed support to be confirmed.
\u201cDemocrats provided the margin of victory for Azar, would have been 48-50 if Dems all voted no https://t.co/UFH9GRsf9n\u201d— David Dayen (@David Dayen) 1516837759
\u201cUS Senate voted 55 to 43 to make @LillyPad CEO Alex Azar head of @HHSGov. \n\nWhich Democrats helped Repubs approve this greedy #BigPharma CEO?\n\n@SenatorCarper - DE\n@ChrisCoons - DE\n@SenDonnelly - IN\n@SenatorHeitkamp - ND\n@GDouglasJones - AL\n@Sen_JoeManchin - WV\n\n#WeWantBetterDems\u201d— RoseAnn DeMoro (@RoseAnn DeMoro) 1516843300
President Donald Trump nominated Azar after his first Health and Human Services Secretary Tom Price was forced to resign last year following revelations he was using taxpayer money to charter private plans for unnecessary trips.
While opponents of his nomination, including advocacy groups like Public Citizen, mounted an aggressive campaign to block Azar's confirmation, in the end it was not enough.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation. "If Azar's record of corruption is any indication of his future behavior, his tenure will be even shorter than his predecessor Tom Price."
Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place. We're hundreds of thousands strong, but every single supporter makes the difference. Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. Join with us today! |
The U.S. Senate on Wednesday, with the help of crucial votes by Democrats, confirmed former Eli Lilly executive Alex Azar to become the nation's top healthcare administrator, provoking ire among progressives and healthcare advocates.
\u201cShame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry: https://t.co/b4Gqxvwedv\u201d— Social Security Works (@Social Security Works) 1516826042
Notable on the rollcall list, and the source of ire among critics, was the fact that six Democratic Senators--Doug Jones of Alabama, Tom Carper of Delaware, Chris Coons of Delaware,Joe Donnelly of Indiana, Heidi Heitkamp of North Dakota, and Joe Manchin of West Virginia --joined with Republicans and voted in favor. With the addition of Sen. Angus King, the Indepedent from Maine who caucuses with the Democrats, that gave Azar the needed support to be confirmed.
\u201cDemocrats provided the margin of victory for Azar, would have been 48-50 if Dems all voted no https://t.co/UFH9GRsf9n\u201d— David Dayen (@David Dayen) 1516837759
\u201cUS Senate voted 55 to 43 to make @LillyPad CEO Alex Azar head of @HHSGov. \n\nWhich Democrats helped Repubs approve this greedy #BigPharma CEO?\n\n@SenatorCarper - DE\n@ChrisCoons - DE\n@SenDonnelly - IN\n@SenatorHeitkamp - ND\n@GDouglasJones - AL\n@Sen_JoeManchin - WV\n\n#WeWantBetterDems\u201d— RoseAnn DeMoro (@RoseAnn DeMoro) 1516843300
President Donald Trump nominated Azar after his first Health and Human Services Secretary Tom Price was forced to resign last year following revelations he was using taxpayer money to charter private plans for unnecessary trips.
While opponents of his nomination, including advocacy groups like Public Citizen, mounted an aggressive campaign to block Azar's confirmation, in the end it was not enough.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation. "If Azar's record of corruption is any indication of his future behavior, his tenure will be even shorter than his predecessor Tom Price."
The U.S. Senate on Wednesday, with the help of crucial votes by Democrats, confirmed former Eli Lilly executive Alex Azar to become the nation's top healthcare administrator, provoking ire among progressives and healthcare advocates.
\u201cShame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry: https://t.co/b4Gqxvwedv\u201d— Social Security Works (@Social Security Works) 1516826042
Notable on the rollcall list, and the source of ire among critics, was the fact that six Democratic Senators--Doug Jones of Alabama, Tom Carper of Delaware, Chris Coons of Delaware,Joe Donnelly of Indiana, Heidi Heitkamp of North Dakota, and Joe Manchin of West Virginia --joined with Republicans and voted in favor. With the addition of Sen. Angus King, the Indepedent from Maine who caucuses with the Democrats, that gave Azar the needed support to be confirmed.
\u201cDemocrats provided the margin of victory for Azar, would have been 48-50 if Dems all voted no https://t.co/UFH9GRsf9n\u201d— David Dayen (@David Dayen) 1516837759
\u201cUS Senate voted 55 to 43 to make @LillyPad CEO Alex Azar head of @HHSGov. \n\nWhich Democrats helped Repubs approve this greedy #BigPharma CEO?\n\n@SenatorCarper - DE\n@ChrisCoons - DE\n@SenDonnelly - IN\n@SenatorHeitkamp - ND\n@GDouglasJones - AL\n@Sen_JoeManchin - WV\n\n#WeWantBetterDems\u201d— RoseAnn DeMoro (@RoseAnn DeMoro) 1516843300
President Donald Trump nominated Azar after his first Health and Human Services Secretary Tom Price was forced to resign last year following revelations he was using taxpayer money to charter private plans for unnecessary trips.
While opponents of his nomination, including advocacy groups like Public Citizen, mounted an aggressive campaign to block Azar's confirmation, in the end it was not enough.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation. "If Azar's record of corruption is any indication of his future behavior, his tenure will be even shorter than his predecessor Tom Price."
